3 reports

  • 5. All the trials included are unique trials.

The investigational product is a transdermal formulation developed using Hisamitsu' s TDDS (Transdermal Drug Delivery System) technology and expected to realize its long-lasting effect by means of maintaining a stable blood concentration.

  • Cardiovascular Drug
  • Clinical Trial
  • Pharmaceutical
  • Psychotic Disorder
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cardiovascular Drug
  • Neurological Disorder
  • Neurology
  • World
  • Shire plc
  • Clinical Trial Profile Snapshots

ND##L is further being developed for future delivery through a small patch pump that should offer a new level of therapy convenience.

  • Cardiovascular Drug
  • Clinical Trial
  • Drug Development
  • Psychotic Disorder
  • World